Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma

NCT07096362 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: 5-Fluorouracil
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: Irinotecan
DRUG: Gemcitabine
DRUG: Nab Paclitaxel
DIAGNOSTIC_TEST: Circulating Tumor Deoxyribonucleic acid (ctDNA) Assay

Sponsor

University of Miami

Collaborators

[object Object]
[object Object]